Abstract：
OBJECTIVE: Mammoplasty, a common cosmetic procedure involving breast augmentation and reduction surgeries, has gained global popularity. Recently, attention has shifted towards understanding the prevalence and significance of gastrointestinal (GI) symptoms following mammoplasty. This systematic review aims to consolidate existing literature to provide a comprehensive overview of the type and frequency of GI problems associated with various mammoplasty procedures.
METHODS: A systematic search of PubMed and Scopus databases was conducted until January 22, 2024, identifying observational and interventional studies examining GI symptoms post-mammoplasty. Inclusion criteria covered human studies, while exclusion criteria ensured specificity. Two independent investigators performed screening, and data extraction included study characteristics, surgical procedures, anesthesia methods, and interventions.
RESULTS: Nineteen studies, involving 2,487 subjects, were included in the review. Breast reconstruction emerged as the most studied procedure, followed by breast reduction, augmentation, mastectomy, and breast cancer surgery. Predominant GI symptoms included nausea and vomiting, with varying rates across mammoplasty types. Anesthesia modality influenced symptomatology, with general, local, and combined anesthesia associated with GI disturbances. Antiemetics, notably ondansetron and droperidol, showed variable efficacy. Non-pharmacological approaches, such as preoperative hypnosis, were explored for symptom management.
CONCLUSIONS: Our systematic review reveals insights into GI symptoms post-mammoplasty, emphasizing the common occurrence of symptoms such as nausea and vomiting, alongside less frequent manifestations such as constipation, dry mouth, retching, abdominal pain, and tightness. Variations in symptom prevalence were noted across diverse mammoplasty surgeries, anesthesia methods, and the use of antiemetics, underscoring the complex nature of post-mammoplasty GI disturbances.
METHODS: A systematic search of PubMed and Scopus databases was conducted until January 22, 2024, identifying observational and interventional studies examining GI symptoms post-mammoplasty. Inclusion criteria covered human studies, while exclusion criteria ensured specificity. Two independent investigators performed screening, and data extraction included study characteristics, surgical procedures, anesthesia methods, and interventions.
RESULTS: Nineteen studies, involving 2,487 subjects, were included in the review. Breast reconstruction emerged as the most studied procedure, followed by breast reduction, augmentation, mastectomy, and breast cancer surgery. Predominant GI symptoms included nausea and vomiting, with varying rates across mammoplasty types. Anesthesia modality influenced symptomatology, with general, local, and combined anesthesia associated with GI disturbances. Antiemetics, notably ondansetron and droperidol, showed variable efficacy. Non-pharmacological approaches, such as preoperative hypnosis, were explored for symptom management.
CONCLUSIONS: Our systematic review reveals insights into GI symptoms post-mammoplasty, emphasizing the common occurrence of symptoms such as nausea and vomiting, alongside less frequent manifestations such as constipation, dry mouth, retching, abdominal pain, and tightness. Variations in symptom prevalence were noted across diverse mammoplasty surgeries, anesthesia methods, and the use of antiemetics, underscoring the complex nature of post-mammoplasty GI disturbances.
摘要：
目的：乳房成形术，涉及隆胸和缩胸手术的常见整容手术，已获得全球知名度。最近,注意力已转移到了解乳房成形术后胃肠道（GI）症状的患病率和重要性。本系统综述旨在巩固现有文献，以全面概述与各种乳房成形术相关的胃肠道问题的类型和频率。
方法：对PubMed和Scopus数据库进行了系统搜索，直到2024年1月22日，确定了检查乳房成形术后胃肠道症状的观察性和介入性研究。纳入标准涵盖人体研究，而排除标准确保了特异性。两名独立研究人员进行了筛查，数据提取包括研究特征，外科手术,麻醉方法,和干预。
结果：19项研究，涉及2487名受试者，包括在审查中。乳房重建成为研究最多的手术，然后是乳房缩小,增强，乳房切除术,和乳腺癌手术。主要的胃肠道症状包括恶心和呕吐，乳房成形术类型的比率不同。麻醉方式影响症状学，一般,当地,以及与胃肠道紊乱相关的联合麻醉。止吐药,尤其是昂丹司琼和氟哌利多,表现出可变的功效。非药理学方法，比如术前催眠,对症状管理进行了探索。
结论：我们的系统评价揭示了乳房成形术后胃肠道症状的见解，强调恶心和呕吐等症状的常见发生，除了便秘等不常见的表现，口干,干涩,腹痛,和紧绷。在不同的乳房整形手术中注意到症状患病率的变化，麻醉方法,以及使用止吐药,强调乳房成形术后胃肠道紊乱的复杂性。
方法：对PubMed和Scopus数据库进行了系统搜索，直到2024年1月22日，确定了检查乳房成形术后胃肠道症状的观察性和介入性研究。纳入标准涵盖人体研究，而排除标准确保了特异性。两名独立研究人员进行了筛查，数据提取包括研究特征，外科手术,麻醉方法,和干预。
结果：19项研究，涉及2487名受试者，包括在审查中。乳房重建成为研究最多的手术，然后是乳房缩小,增强，乳房切除术,和乳腺癌手术。主要的胃肠道症状包括恶心和呕吐，乳房成形术类型的比率不同。麻醉方式影响症状学，一般,当地,以及与胃肠道紊乱相关的联合麻醉。止吐药,尤其是昂丹司琼和氟哌利多,表现出可变的功效。非药理学方法，比如术前催眠,对症状管理进行了探索。
结论：我们的系统评价揭示了乳房成形术后胃肠道症状的见解，强调恶心和呕吐等症状的常见发生，除了便秘等不常见的表现，口干,干涩,腹痛,和紧绷。在不同的乳房整形手术中注意到症状患病率的变化，麻醉方法,以及使用止吐药,强调乳房成形术后胃肠道紊乱的复杂性。
